← Eichor
Study identifier: NCT06309199 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevalence of FGIDs and Probiotics Study

Condition: Functional Gastrointestinal Disorders · Infant Conditions  ·  Sponsor: Chulalongkorn University

PhaseNA
Planned participants512
Who can joinAll sexes, 3 Days to 1 Year
Healthy volunteersYes

About this study

This is a study to evaluate the prevalence of FGIDs in infants using the Thai version of Rome IV diagnostic questionnaire for functional gastrointestinal disorders in infants and evaluate the efficacy of Limosilactobacillus reuteri DSM 17938 to prevent FGIDs in infants.

This description comes directly from the study's public registry record.

Talk to the study team

Palittiya Sintusek, PhD  ·  +66818288082  ·  palittiya.s@chula.ac.th

Sittichoke Prachuapthunyachart, MD  ·  +66829740649  ·  sittichoke.p@chula.ac.th

Always discuss trial participation with your own doctor first.

Locations (1)

Maha Chakri Sirindhorn Clinical Research Center (Chula CRC)Bangkok, Bangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06309199